Related references
Note: Only part of the references are listed.Deferasirox effectively reduces iron overload in non-transfusion-dependent thalassemia (NTDT) patients: 1-year extension results from the THALASSA study
Ali T. Taher et al.
ANNALS OF HEMATOLOGY (2013)
Elevated liver iron concentration is a marker of increased morbidity in patients with β thalassemia intermedia
Khaled M. Musallam et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2011)
Liver biopsy results in patients with sickle cell disease on chronic transfusions: Poor correlation with ferritin levels
Lina B. Karam et al.
PEDIATRIC BLOOD & CANCER (2008)
Adherence to deferoxamine therapy: Heeding hippocrates and osler
F Watkins et al.
AMERICAN JOURNAL OF HEMATOLOGY (2004)
Share Paper
